Skip to main content
Top
Published in: Journal of Cancer Survivorship 5/2017

01-10-2017

Specialized survivor clinic attendance increases adherence to cardiomyopathy screening guidelines in adult survivors of childhood cancer

Authors: Kristin C. Marr, Mohammad Agha, Rinku Sutradhar, Jason D. Pole, David Hodgson, Astrid Guttmann, Mark Greenberg, Paul C. Nathan

Published in: Journal of Cancer Survivorship | Issue 5/2017

Login to get access

Abstract

Purpose

To determine if attendance at a specialized clinic for adult survivors of childhood cancer is associated with better rates of adherence to the Children’s Oncology Group (COG) Long-term Follow-up (LTFU) guidelines for cardiomyopathy screening.

Methods

We conducted a retrospective population-based study using administrative data in Ontario, Canada of 5-year survivors diagnosed between 1986 and 2005 at risk of therapy-related late cardiomyopathy. Patients were classified into three groups based on the recommended frequency of screening: annual, every 2 years, and every 5 years.

Results

Of 1811 eligible survivors followed for median 7.8 years (range 0–14.0), patients were adherent to screening for only 8.6% of their period of follow-up. Survivor clinic utilization had the strongest association with increased rates of adherence: when compared to no attendance, ≥ 5 clinic visits/10-year period had RR of adherence of 10.6 (95% CI 5.7–19.5) in the annual group, 3.3 (95% CI 2.3–4.8) in the every 2-year group, and 2.3 (95% CI 1.6–3.2) in the every 5-year group. Additional factors associated with increased adherence after adjusting for clinic attendance included annual assessment by a general practioner, female sex, diagnosis prior to 2003, and living in a rural area.

Conclusions

In a model of specialized survivor care, increased clinic utilization is associated with improved patient adherence to COG LTFU cardiomyopathy screening guidelines.

Implications for cancer survivors

Specialized survivor clinics may improve health outcomes in survivors through improved adherence to screening. However, rates of adherence remain suboptimal and further multifacetted strategies need to be explored to improve overall rates of screening in adult survivors of childhood cancer.
Appendix
Available only for authorised users
Literature
1.
go back to reference Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2014, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2014/, based on November 2016 SEER data submission, posted to the SEER website, April 2017. Accessed July 17, 2017. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975–2014, National Cancer Institute. Bethesda, MD, https://​seer.​cancer.​gov/​csr/​1975_​2014/​, based on November 2016 SEER data submission, posted to the SEER website, April 2017. Accessed July 17, 2017.
2.
go back to reference Gatta G, Zigon G, Capocaccia R, et al. Survival of European children and young adults with cancer diagnosed 1995–2002. Eur J Cancer. 2009;45:992–1005.CrossRefPubMed Gatta G, Zigon G, Capocaccia R, et al. Survival of European children and young adults with cancer diagnosed 1995–2002. Eur J Cancer. 2009;45:992–1005.CrossRefPubMed
4.
go back to reference Phillips SM, Padgett LS, Leisenring WM, et al. Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidemiol Biomark Prev. 2015;24:653–63.CrossRef Phillips SM, Padgett LS, Leisenring WM, et al. Survivors of childhood cancer in the United States: prevalence and burden of morbidity. Cancer Epidemiol Biomark Prev. 2015;24:653–63.CrossRef
5.
go back to reference Armstrong GT, Joshi VM, Ness KK, et al. Comprehensive echocardiographic detection of treatment-related cardiac dysfunction in adult survivors of childhood cancer: Results from the St. Jude lifetime cohort study. J Am Coll Cardiol. 2015;65:2511–22.CrossRefPubMedPubMedCentral Armstrong GT, Joshi VM, Ness KK, et al. Comprehensive echocardiographic detection of treatment-related cardiac dysfunction in adult survivors of childhood cancer: Results from the St. Jude lifetime cohort study. J Am Coll Cardiol. 2015;65:2511–22.CrossRefPubMedPubMedCentral
6.
go back to reference Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572–82.CrossRefPubMed Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572–82.CrossRefPubMed
7.
go back to reference Institute of Medicine. National Research Council National Cancer Policy B. In: Hewitt M, Weiner SL, Simone JV, editors. Childhood cancer survivorship: improving care and quality of life. Washington (DC): National Academies Press (US); 2003. Institute of Medicine. National Research Council National Cancer Policy B. In: Hewitt M, Weiner SL, Simone JV, editors. Childhood cancer survivorship: improving care and quality of life. Washington (DC): National Academies Press (US); 2003.
9.
go back to reference Armstrong GT, Oeffinger KC, Chen Y, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013;31:3673–80.CrossRefPubMedPubMedCentral Armstrong GT, Oeffinger KC, Chen Y, et al. Modifiable risk factors and major cardiac events among adult survivors of childhood cancer. J Clin Oncol. 2013;31:3673–80.CrossRefPubMedPubMedCentral
10.
go back to reference Habash-Bseiso DE, Rokey R, Berger CJ, et al. Accuracy of noninvasive ejection fraction measurement in a large community-based clinic. Clin Med Res. 2005;3:75–82.CrossRefPubMedPubMedCentral Habash-Bseiso DE, Rokey R, Berger CJ, et al. Accuracy of noninvasive ejection fraction measurement in a large community-based clinic. Clin Med Res. 2005;3:75–82.CrossRefPubMedPubMedCentral
11.
go back to reference Cardinale D, Colombo A, Lamantia G, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol. 2010;55:213–20.CrossRefPubMed Cardinale D, Colombo A, Lamantia G, et al. Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol. 2010;55:213–20.CrossRefPubMed
12.
go back to reference Lipshultz E, Lipsitz SR, Sallan SE, et al. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol. 2002;20:4517–22.CrossRefPubMed Lipshultz E, Lipsitz SR, Sallan SE, et al. Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol. 2002;20:4517–22.CrossRefPubMed
13.
go back to reference Wong FL, Bhatia S, Landier W, et al. Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure. Ann Intern Med. 2014;160:672–83.CrossRefPubMedPubMedCentral Wong FL, Bhatia S, Landier W, et al. Cost-effectiveness of the children's oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure. Ann Intern Med. 2014;160:672–83.CrossRefPubMedPubMedCentral
14.
go back to reference Greenberg ML, Barr RD, DiMonte B, et al. Childhood cancer registries in Ontario, Canada: lessons learned from a comparison of two registries. Int J Cancer. 2003;105:88–91.CrossRefPubMed Greenberg ML, Barr RD, DiMonte B, et al. Childhood cancer registries in Ontario, Canada: lessons learned from a comparison of two registries. Int J Cancer. 2003;105:88–91.CrossRefPubMed
15.
go back to reference Nathan PC, Agha M, Pole JD, et al. Predictors of attendance at specialized survivor clinics in a population-based cohort of adult survivors of childhood cancer. J Cancer Surviv. 2016;10:611–8.CrossRefPubMed Nathan PC, Agha M, Pole JD, et al. Predictors of attendance at specialized survivor clinics in a population-based cohort of adult survivors of childhood cancer. J Cancer Surviv. 2016;10:611–8.CrossRefPubMed
16.
go back to reference Kazak AE, Hocking MC, Ittenbach RF, et al. A revision of the intensity of treatment rating scale: classifying the intensity of pediatric cancer treatment. Pediatr Blood Cancer. 2012;59:96–9.CrossRefPubMed Kazak AE, Hocking MC, Ittenbach RF, et al. A revision of the intensity of treatment rating scale: classifying the intensity of pediatric cancer treatment. Pediatr Blood Cancer. 2012;59:96–9.CrossRefPubMed
17.
go back to reference Kralj B. Measuring “rurality” for purposes of health care planning: an empirical measure for Ontario. Ontario Medical Association: Toronto; 2005. Kralj B. Measuring “rurality” for purposes of health care planning: an empirical measure for Ontario. Ontario Medical Association: Toronto; 2005.
18.
go back to reference Matheson FI, Dunn JR, Smith KL, et al. Development of the Canadian Marginalization Index: a new tool for the study of inequality. Can J Public Health. 2012;103:S12–6.PubMed Matheson FI, Dunn JR, Smith KL, et al. Development of the Canadian Marginalization Index: a new tool for the study of inequality. Can J Public Health. 2012;103:S12–6.PubMed
19.
go back to reference McCullagh PN, Nelder JA. Monographs on statistics and applied probability: Generalized Linear Models, Second Edition. London: Chapman & Hall, 1989. Print. McCullagh PN, Nelder JA. Monographs on statistics and applied probability: Generalized Linear Models, Second Edition. London: Chapman & Hall, 1989. Print.
20.
go back to reference Nathan PC, Greenberg ML, Ness KK, et al. Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2008;26:4401–9.CrossRefPubMedPubMedCentral Nathan PC, Greenberg ML, Ness KK, et al. Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study. J Clin Oncol. 2008;26:4401–9.CrossRefPubMedPubMedCentral
21.
go back to reference Landier W, Chen Y, Namdar G, et al. Impact of tailored education on awareness of personal risk for therapy-related complications among childhood cancer survivors. J Clin Oncol. 2015;33:3887–93.CrossRefPubMedPubMedCentral Landier W, Chen Y, Namdar G, et al. Impact of tailored education on awareness of personal risk for therapy-related complications among childhood cancer survivors. J Clin Oncol. 2015;33:3887–93.CrossRefPubMedPubMedCentral
22.
go back to reference Hudson MM, Leisenring W, Stratton KK, et al. Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial. J Clin Oncol. 2014;32:3974–81.CrossRefPubMedPubMedCentral Hudson MM, Leisenring W, Stratton KK, et al. Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial. J Clin Oncol. 2014;32:3974–81.CrossRefPubMedPubMedCentral
23.
24.
go back to reference Daniel CL, Kohler CL, Stratton KL, et al. Predictors of colorectal cancer surveillance among survivors of childhood cancer treated with radiation: a report from the Childhood Cancer Survivor Study. Cancer. 2015;121:1856–63.CrossRefPubMedPubMedCentral Daniel CL, Kohler CL, Stratton KL, et al. Predictors of colorectal cancer surveillance among survivors of childhood cancer treated with radiation: a report from the Childhood Cancer Survivor Study. Cancer. 2015;121:1856–63.CrossRefPubMedPubMedCentral
25.
go back to reference Nathan PC, Ness KK, Mahoney MC, et al. Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med. 2010;153:442–51.CrossRefPubMedPubMedCentral Nathan PC, Ness KK, Mahoney MC, et al. Screening and surveillance for second malignant neoplasms in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Ann Intern Med. 2010;153:442–51.CrossRefPubMedPubMedCentral
26.
go back to reference Yeazel MW, Oeffinger KC, Gurney JG, et al. The cancer screening practices of adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2004;100:631–40.CrossRefPubMed Yeazel MW, Oeffinger KC, Gurney JG, et al. The cancer screening practices of adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2004;100:631–40.CrossRefPubMed
27.
go back to reference Ristovski-Slijepcevic S, Barr R, Bernstein M, Nathan PC. A cross-Canada survey of clinical programs for the care of survivors of cancer in childhood and adolescence. Paediatr Child Health. 2009;14:375–8.PubMedPubMedCentral Ristovski-Slijepcevic S, Barr R, Bernstein M, Nathan PC. A cross-Canada survey of clinical programs for the care of survivors of cancer in childhood and adolescence. Paediatr Child Health. 2009;14:375–8.PubMedPubMedCentral
28.
go back to reference Essig S, Skinner R, von der Weid NX, et al. Follow-up programs for childhood cancer survivors in Europe: a questionnaire survey. PLoS One. 2012;7:e53201.CrossRefPubMedPubMedCentral Essig S, Skinner R, von der Weid NX, et al. Follow-up programs for childhood cancer survivors in Europe: a questionnaire survey. PLoS One. 2012;7:e53201.CrossRefPubMedPubMedCentral
29.
go back to reference Suh E, Daugherty CK, Wroblewski K, et al. General internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey. Ann Intern Med. 2014;160:11–7.CrossRefPubMedPubMedCentral Suh E, Daugherty CK, Wroblewski K, et al. General internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey. Ann Intern Med. 2014;160:11–7.CrossRefPubMedPubMedCentral
30.
go back to reference Nathan PC, Daugherty CK, Wroblewski KE, et al. Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer. J Cancer Surviv. 2013;7:275–82.CrossRefPubMed Nathan PC, Daugherty CK, Wroblewski KE, et al. Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer. J Cancer Surviv. 2013;7:275–82.CrossRefPubMed
31.
go back to reference Wu H, Zhu K, Jatoi I, et al. Factors associated with the incompliance with mammogram screening among individuals with a family history of breast cancer or ovarian cancer. Breast Cancer Res Treat. 2007;101:317–24.CrossRefPubMed Wu H, Zhu K, Jatoi I, et al. Factors associated with the incompliance with mammogram screening among individuals with a family history of breast cancer or ovarian cancer. Breast Cancer Res Treat. 2007;101:317–24.CrossRefPubMed
32.
go back to reference Armenian SH, Hudson MM, Mulder RL, et al. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015;16:e123–36.CrossRefPubMedPubMedCentral Armenian SH, Hudson MM, Mulder RL, et al. Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Lancet Oncol. 2015;16:e123–36.CrossRefPubMedPubMedCentral
Metadata
Title
Specialized survivor clinic attendance increases adherence to cardiomyopathy screening guidelines in adult survivors of childhood cancer
Authors
Kristin C. Marr
Mohammad Agha
Rinku Sutradhar
Jason D. Pole
David Hodgson
Astrid Guttmann
Mark Greenberg
Paul C. Nathan
Publication date
01-10-2017
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 5/2017
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-017-0634-z

Other articles of this Issue 5/2017

Journal of Cancer Survivorship 5/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine